TAP Consulting’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-8,734
| Closed | -$253K | – | 158 |
|
|
2024
Q3 | $253K | Buy |
8,734
+230
| +3% | +$6.71K | 0.05% | 141 |
|
|
2024
Q2 | $238K | Buy |
8,504
+372
| +5% | +$10.2K | 0.05% | 148 |
|
|
2024
Q1 | $226K | Sell |
8,132
-252
| -3% | -$6.99K | 0.05% | 145 |
|
|
2023
Q4 | $241K | Buy |
8,384
+100
| +1% | +$3.02K | 0.06% | 119 |
|
|
2023
Q3 | $275K | Sell |
8,284
-7,152
| -46% | -$253K | 0.07% | 118 |
|
|
2023
Q2 | $566K | Sell |
15,436
-569
| -4% | -$22.1K | 0.14% | 104 |
|
|
2023
Q1 | $653K | Sell |
16,005
-907
| -5% | -$39.2K | 0.16% | 94 |
|
|
2022
Q4 | $867K | Buy |
16,912
+69
| +0.4% | +$3.31K | 0.23% | 81 |
|
|
2022
Q3 | $737K | Buy |
16,843
+82
| +0.5% | +$3.98K | 0.2% | 79 |
|
|
2022
Q2 | $879K | Sell |
16,761
-317
| -2% | -$16.2K | 0.24% | 72 |
|
|
2022
Q1 | $884K | Sell |
17,078
-4,362
| -20% | -$226K | 0.23% | 77 |
|
|
2021
Q4 | $1.27M | Buy |
21,440
+783
| +4% | +$38.8K | 0.29% | 71 |
|
|
2021
Q3 | $888K | Buy |
20,657
+24
| +0.1% | +$1.06K | 0.24% | 84 |
|
|
2021
Q2 | $808K | Buy |
20,633
+246
| +1% | +$9.57K | 0.23% | 84 |
|
|
2021
Q1 | $739K | Buy |
20,387
+196
| +1% | +$6.96K | 0.23% | 83 |
|
|
2020
Q4 | $743K | Buy |
20,191
+3,171
| +19% | +$116K | 0.27% | 77 |
|
|
2020
Q3 | $593K | Sell |
17,020
-84
| -0.5% | -$2.94K | 0.23% | 80 |
|
|
2020
Q2 | $531K | Sell |
17,104
-929
| -5% | -$31.6K | 0.26% | 76 |
|
|
2020
Q1 | $558K | Buy |
18,033
+1,089
| +6% | +$37.1K | 0.38% | 71 |
|
|
2019
Q4 | $630K | Sell |
16,944
-220
| -1% | -$7.84K | 0.35% | 69 |
|
|
2019
Q3 | $585K | Buy |
+17,164
| New | +$624K | 0.35% | 71 |
|
|
2019
Q1 | $671K | Buy |
+16,665
| New | +$667K | 0.51% | 58 |
|
Other funds holding PFE
